Fecal lipocalin-2 levels were elevated ~4–5-fold in active ulcerative colitis and active Crohn’s disease compared to patients with inactive disease, the latter still being ~4–5-fold higher compared to stool from healthy controls (Figure 2). Here, LCN2 is linked to ulcerative colitis.